Page 5 - Read Online

Hepatoma Research

C O NT E NT S

Topic: Systemic Treatment for Hepatocellular Carcinoma

Commentary
1 Systemic therapies for hepatocellular carcinoma: an evolving landscape
Filippo Pelizzaro, Giuliano Ramadori, Fabio Farinati
Hepatoma Res 2021;7:36. https://doi.org/10.20517/2394-5079.2021.24

Original Article
2 BOOST: a phase 3 trial of sorafenib vs. best supportive care in first line treatment of
hepatocellular carcinoma in patients with deteriorated liver function
Gennaro Daniele, Clorinda Schettino, Laura Arenare, Domenico Bilancia, Fabio Farinati,
Piera Federico, Stefano Tamberi, Gino Crivellari, Sandro Barni, Raffaella Tortora, Francesco
Izzo, Antonio Frassoldati, Luigi Cavanna, Claudia Mucciarini, Luigi Bolondi, Angelo Dinota,
Filippo Pelizzaro,Maria Carmela Piccirillo, Piera Gargiulo, Massimo Di Maio, Ciro Gallo,
Francesco Perrone, Bruno Daniele
Hepatoma Res 2021;7:61. https://doi.org/10.20517/2394-5079.2021.58

Perspective
3 Neoadjuvant and adjuvant systemic treatment for hepatocellular carcinoma
Maria Cecilia Mathias-Machado, Leonardo G. da Fonseca
Hepatoma Res 2021;7:67. https://doi.org/10.20517/2394-5079.2021.84

4 Understanding immune perspectives and options for the use of checkpoint immunotherapy
in HCC post liver transplant
Chimaobi M. Anugwom, Thomas M. Leventhal, Jose D. Debes
Hepatoma Res 2022;8:7. https://doi.org/10.20517/2394-5079.2021.123

Review
5 Issue on combined locoregional and systemic treatment for hepatocellular carcinoma
Yi-Chia (Jasmine) Wu, Ali Wakil, Fayssa Salomon, Nikolaos Pyrsopoulos
Hepatoma Res 2023;9:6. https://doi.org/10.20517/2394-5079.2022.37

Editorial
6 Current landscape and future directions for systemic treatments of hepatocellular carcinoma
Leonardo G. Fonseca, Flair J. Carrilho
Hepatoma Res 2023;9:27. https://doi.org/10.20517/2394-5079.2023.63

Hepatoma Research III